Protein models in drug discovery

Current Opinion in Drug Discovery and Development

Volumn 4, Issue 3, 2001, Pages 284-290

  Norin, M ^a   Sundstrom M ^a  

^a BIOVITRUM AB   (Sweden)

Author keywords

Fold recognition; Protein structures; Structural genomics; Structure prediction; Structure based design

Indexed keywords

PROTEIN;

DRUG IDENTIFICATION; GENE MAPPING; GENOME; METHODOLOGY; PREDICTION; PROTEIN ANALYSIS; PROTEIN FOLDING; PROTEIN STRUCTURE; REVIEW; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; BINDING SITES; DRUG DESIGN; MODELS, MOLECULAR; PHARMACOLOGY; POLYMORPHISM, GENETIC; PROTEIN FOLDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; PROTEINS;

EID: 0034981788     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Initial sequencing and analysis of the human genome
2. The sequence of the human genome
3. The role of innovation in drug development
4. Genomic biology
5. An assessment of gene prediction accuracy in large DNA-sequences
6. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs
7. Profile hidden Markov models
8. The Pfam protein families database
9. Finding families for genomic ORFans
10. A combined algorithm for genome-wide prediction of protein function
11. An overview of structural genomics
12. Protein structure modeling for structural genomics
13. GenBank
14. Calculation of conformational ensembles from potentials of mean force. An approach to the knowledge-based prediction of local structures in globular proteins
15. Threading analysis suggests that the obese gene product may be a helical cytokine
16. Combination of threading potentials and sequence profiles improves fold recognition
17. Predicting protein three-dimensional structure
18. Protein structure prediction in the postgenomic era
19. Enhanced genome annotation using structural profiles in the program 3D-PSSM
20. The PROSITE database, its status in 1999
21. Three-dimensional structure analysis of PROSITE patterns
22. Protein clefts in molecular recognition and function
23. Fast prediction and visualization of protein binding pockets with PASS
24. Automatic identification and representation of protein binding sites for molecular docking
25. A hot spot of binding energy in a hormone-receptor interface
26. 1ribonucleases
27. Structure-based functional motif identifies a potential disulphide oxidoreductase active site in the serine/threonine protein phosphatase-1 subfamily
28. Structure-based assignment of the biochemical function of a hypothetical protein: A test case of structural genomics
29. Modelling prior distributions of atoms for macromolecular refinement and completion
30. Structure-based design of COX-2 selectivity into flurbiprofen
31. Stability engineering of antibody single-chain Fv fragments
32. Protein production: Feeding the crystallographers and NMR spectroscopists
33. Two exposed amino acid residues confer thermostability on a cold shock protein
34. Rational design and purification of human Bruton's tyrosine kinase SH3-SH2 protein for structure-function studies
35. Engineering therapeutic proteins
36. A T-cell-selective interleukin 2 mutein exhibits potent antitumour activity and is well tolerated in vivo
37. When fold is not important: A common structural framework for adenine and AMP binding in 12 unrelated protein families
38. Molecular scaffold-based design and comparison of combinatorial libraries focused on the ATP-binding site of protein kinases
39. Design, docking and evaluation of multiple libraries against multiple targets
40. Structural mechanism for STI-571 inhibition of Abelson tyrosine kinase
41. Docking ligands onto binding site representations derived from proteins built by homology modelling
42. High throughput docking for library design and library prioritization
43. Design and characterization of the orally active Arg-Gly-Asp peptidomimetic vitronectin receptor SB265123 for prevention of bone loss in osteoporosis
44. Design of GFB-111, a platelet-derived growth factor binding molecule with antiangiogenic and anticancer activity against human tumors in mice
45. Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells
46. Rational design of cytotoxic T-cell inhibitors
47. Towards a structural basis of human non-synonymous nucleotide polymorphisms